Stimulation device and method for treating cardiovascular disease

US9227079B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9227079-B2
Application numberUS-201414197356-A
CountryUS
Kind codeB2
Filing dateMar 5, 2014
Priority dateMar 19, 2009
Publication dateJan 5, 2016
Grant dateJan 5, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A stimulation device and method for treating cardiovascular disease in a human or an animal is provided, the method including placing a magnetic pulse application unit including a coil on a skin surface of a region of the human or the animal, and generating magnetic pulses around the coil, wherein the magnetic pulses induce currents in tissues in the region to stimulate a vagus nerve. The region may be a neck region or a chest region.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for treating cardiovascular disease in a human or an animal, the method comprising: placing a magnetic pulse application unit including a coil on a skin surface of a region of the human or the animal; and generating magnetic pulses around the coil, the magnetic pulses inducing currents in tissues in the region of the human or the animal to stimulate a vagus nerve, wherein the generating magnetic pulses to stimulate the vagus nerve is performed in conjunction with reperfusion therapy, wherein the cardiovascular disease is acute myocardial infarction. 2. The method of claim 1 , wherein the region is a neck region. 3. The method of claim 1 , wherein the region is a chest region. 4. The method of claim 1 , further comprising: cooling the coil by providing an air flow along a winding of the coil. 5. The method of claim 1 , wherein the generating magnetic pulses to stimulate the vagus nerve starts before the reperfusion therapy. 6. The method of claim 1 , wherein the generating magnetic pulses comprises generating magnetic pulses so as to obtain more than 5% decrease in heart rate of the human or the animal when the magnetic pulses are applied compared to the heart rate when the magnetic pulses are not applied. 7. The method of claim 1 , wherein the generating magnetic pulses comprises generating magnetic pulses with a frequency in a range between 5 Hz and 30 Hz. 8. The method of claim 1 , wherein the generating magnetic pulses comprises generating a plurality of pulse trains with an inter-train interval for a time duration in a range between 0.5 hours and 96 hours. 9. The method of claim 8 , wherein the generating magnetic pulses comprises generating the pulse train for a time duration in a range between 6 seconds and 20 seconds and the inter-train interval in a range between 40 seconds and 54 seconds. 10. The method of claim 1 , wherein the generating magnetic pulses comprises generating magnetic pulses having an amplitude and a time variation to induce the currents of about 15 mA/cm 2 in the tissues. 11. A magnetic stimulation device for treating cardiovascular disease in a human or an animal comprising: a magnetic pulse application unit including a coil configured for placement on a skin surface of a region of the human or the animal; and a magnetic pulse generation unit coupled to the magnetic pulse application unit and configured to generate magnetic pulses around the coil, the magnetic pulses inducing currents in tissues in the region of the human or the animal to stimulate a vagus nerve, wherein the cardiovascular disease is acute myocardial infarction, and the magnetic stimulation device is used in conjunction with reperfusion therapy. 12. The magnetic stimulation device of claim 11 , wherein the region is a neck region. 13. The magnetic stimulation device of claim 11 , wherein the region is a chest region. 14. The magnetic stimulation device of claim 11 , further comprising: a cooling unit coupled to the magnetic pulse application unit and configured to provide an air flow along a winding of the coil to cool the coil. 15. The magnetic stimulation device of claim 11 , wherein the magnetic pulse generation unit is configured to be controlled to generate magnetic pulses to stimulate the vagus nerve before the reperfusion therapy. 16. The magnetic stimulation device of claim 11 , further comprising: a control unit configured to control the magnetic pulse generation unit for generation of the magnetic pulses. 17. The magnetic stimulation device of claim 11 , wherein the magnetic pulse generation unit is configured to be controlled for generation of the magnetic pulses so as to obtain more than 5% decrease in heart rate of the human or the animal when the magnetic pulses are applied compared to the heart rate when the magnetic pulses are not applied. 18. The magnetic stimulation device of claim 11 , wherein the magnetic pulse generation unit is configured to be controlled for generation of the magnetic pulses with a frequency in a range between 5 Hz and 30 Hz. 19. The magnetic stimulation device of claim 11 , wherein the magnetic pulse generation unit is configured to be controlled to generate a plurality of pulse trains with an inter-train interval for a time duration in a range between 0.5 hours and 96 hours. 20. The magnetic stimulation device of claim 19 , wherein the magnetic pulse generation unit is configured to be controlled to generate the pulse train for a time duration in a range between 6 seconds and 20 seconds and the inter-train interval in a range between 40 seconds and 54 seconds. 21. The magnetic stimulation device of claim 11 , wherein the magnetic pulse generation unit is configured to be controlled to generate the magnetic pulses having an amplitude and a time variation to induce the currents of about 15 mA/cm 2 in the tissues.

Assignees

Inventors

Classifications

  • A61N2/02Primary

    using magnetic fields produced by coils, including single turn loops or electromagnets (A61N2/12 takes precedence) · CPC title

  • Frequency · CPC title

  • for magnetic stimulation of nerve tissue · CPC title

  • for treating hypertension · CPC title

  • adapted for vagal stimulation (A61N1/36114 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9227079B2 cover?
A stimulation device and method for treating cardiovascular disease in a human or an animal is provided, the method including placing a magnetic pulse application unit including a coil on a skin surface of a region of the human or the animal, and generating magnetic pulses around the coil, wherein the magnetic pulses induce currents in tissues in the region to stimulate a vagus nerve. The regio…
Who is the assignee on this patent?
Univ Kyushu Nat Univ Corp
What technology area does this patent fall under?
Primary CPC classification A61N2/02. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).